Understanding the Potential Role of Abrocitinib in the Time of SARS-CoV-2.

Uppal, Shelley K; Kearns, Donovan G; Chat, Vipawee S; Wu, Jashin J

Uppal, Shelley K; Kearns, Donovan G; Chat, Vipawee S; Wu, Jashin J.

J Drugs Dermatol ; 20(7): 806, 2021 Jul 01.

Article in English | MEDLINE | ID: covidwho-1299843

Subject(s)

COVID-19/complications; Cytokine Release Syndrome/drug therapy; Cytokine Release Syndrome/etiology; Enzyme Inhibitors/therapeutic use; Janus Kinase 1/antagonists & inhibitors; Pyrimidines/therapeutic use; Respiratory Distress Syndrome/drug therapy; Respiratory Distress Syndrome/etiology; Sulfonamides/therapeutic use; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pyrimidines / Respiratory Distress Syndrome / Sulfonamides / Enzyme Inhibitors / Janus Kinase 1 / Cytokine Release Syndrome / COVID-19 Topics: Long Covid Limits: Humans Language: English Journal: J Drugs Dermatol Journal subject: Dermatology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google